2024 ICD-10-CM Diagnosis Code J98.4

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

• Acquired bronchogenic cyst
• Bulla of lung
• Calcification of lung
• Cavitation of lung
• Cavitation of lung
• Cavitation of lung
• Chronic cavitary pulmonary aspergillosis
• Chronic lung disease
• Chronic lung disease due to surfactant disorder
• Chronic pulmonary aspergillosis
• Cystic-bullous disease of the lung
• Diffuse pulmonary calcinosis
• Discoloration of lung
• Disorder of lung
• Disorder of lung due to immunoglobulin A vasculitis
• Erythrocytosis due to pulmonary disease
• Erythrocytosis due to tissue hypoxemia
• FEV1/FVC ratio abnormal
• Hemosiderosis
• Idiopathic diffuse pulmonary ossification
• Infected bronchogenic cyst
• Infection by Pneumocystis jirovecii
• Infection of lung caused by Pneumocystis
• Lung cyst
• Lung cyst
• Lung disease due to connective tissue disorder
• Lung disorder due to autoimmune disorder
• Lung disorder due to autoimmune disorder
• Lung function mildly obstructed
• Lymphocytic pseudotumor of lung
• Micronodular pulmonary ossification
• Milk-induced pulmonary disease in infant
• Multiple lung cysts
• Multiple nodules of lung
• Non-smoker's second hand smoke syndrome
• Occupational lung disease
• Pneumocystis jirovecii lung cyst
• Pneumocystosis
• Pulmolithiasis
• Pulmonary aspergillosis
• Pulmonary cavity following infection by Coccidioides
• Pulmonary hyalinizing granuloma
• Pulmonary hypertension due to lung disease and/or hypoxia
• Pulmonary nodular lymphoid hyperplasia
• Pulmonary ossification
• Pulmonary toxicity
• Restrictive lung disease
• Restrictive lung disease
• Restrictive lung disease
• Restrictive lung disease due to kyphoscoliosis
• Restrictive lung disease due to muscular dystrophy
• Right ventricular failure due to pulmonary disease
• Right ventricular failure due to pulmonary vascular disease
• Secondary hemosiderosis
• Secondary pulmonary hemosiderosis
• Smoker's respiratory syndrome
• Squamous metaplasia of lung
• Uremic lung

Clinical Information

• Hemosiderosis

  conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the mononuclear phagocyte system, without demonstrable tissue damage. the name refers to the presence of stainable iron in the tissue in the form of hemosiderin.

• Invasive Pulmonary Aspergillosis

  lung infections with the invasive forms of aspergillus, usually after surgery, transplantation, prolonged neutropenia or treatment with high-doses of corticosteroids. invasive pulmonary aspergillosis can progress to chronic necrotizing pulmonary aspergillosis or hematogenous spread to other organs.

• Pulmonary Aspergillosis

  infections of the respiratory tract with fungi of the genus aspergillus.

• Mononuclear Phagocyte System

  mononuclear cells with pronounced phagocytic ability that are distributed extensively in lymphoid and other organs. it includes macrophages and their precursors; phagocytes; kupffer cells; histiocytes; dendritic cells; langerhans cells; and microglia. the term mononuclear phagocyte system has replaced the former reticuloendothelial system, which also included less active phagocytic cells such as fibroblasts and endothelial cells. (from illustrated dictionary of immunology, 2d ed.)

• Aspergillus

  a genus of mitosporic fungi containing about 100 species and eleven different teleomorphs in the family trichocomaceae.

• Restrictive Lung Disease

  decreased lung volume and inadequate ventilation due to parenchymal lung disorders (e.g., interstitial pulmonary fibrosis) or extrapulmonary disorders (e.g., scoliosis). patients present with shortness of breath and cough.

• Chronic Pulmonary Aspergillosis

  a spectrum of disorders associated with long-term aspergillus infection of the lung that usually occur in immunocompetent individuals with underlying respiratory disorders, and may be characterized by pulmonary fibrosis or cavitation.

• Pulmonary Toxicity

  toxicity that impairs or damages the lung(s). this condition is often caused by the administration of a pharmaceutical agent that causes damage to the lungs.

J98.4 is grouped with Diagnostic Related Groups - MS-DRG Mapping

Diagnostic Related Groups (DRGs) are a classification system used to group together diagnosis codes for the purpose of reimbursement and healthcare management. DRGs are used to standardize the way hospitals and other providers are paid for inpatient services. In this system patients are grouped together based on their principal diagnosis in areas referred to as Major Diagnostic Categories (MDC). Once a patient is assigned a particular diagnostic category, providers receive a predetermined payment rate for the services rendered. This reimbursement rate is often fixed and is meant to cover the cost of care for that patient. Reimbursement is also affected by the relative weight of a diagnostic related group based on the severity of a patient's illness and the associated cost of care during hospitalization.

Diagnostic related groups encourage healthcare providers to focus on quality and efficiency in patient care while managing costs effectively. The diagnosis code is present in the following groups for version MS-DRG V41.0 applicable from 10/01/2023 through 09/30/2024.

The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.

Convert J98.4 to ICD-9-CM

• ICD-9-CM Code: 518.89 - Other lung disease NEC

Patient Education

Lung Diseases

When you breathe, your lungs take in oxygen from the air and deliver it to the bloodstream. The cells in your body need oxygen to work and grow. During a normal day, you breathe nearly 25,000 times. People with lung disease have difficulty breathing. Millions of people in the U.S. have lung disease. If all types of lung disease are lumped together, it is the number three killer in the United States.

The term lung disease refers to many disorders affecting the lungs, such as asthma, COPD, infections like influenza, pneumonia and tuberculosis, lung cancer, and many other breathing problems. Some lung diseases can lead to respiratory failure.

Dept. of Health and Human Services Office on Women's Health

Code History

• FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
• FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
• FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
• FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
• FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
• FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
• FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
• FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
• FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.